How academic labs can approach the drug discovery process as a way to synergize with big pharma

Trends Microbiol. 2013 Jun;21(6):261-4. doi: 10.1016/j.tim.2013.03.006.


While the pharmaceutical industry is facing highly challenging times, the academic drug discovery sector has the potential to contribute meaningfully to the discovery of novel drug targets and to the development of new mode-of-action therapeutics against a range of diseases, including rare and neglected diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Academic Medical Centers / organization & administration*
  • Biomedical Research
  • Drug Discovery*
  • Drug Industry / organization & administration*
  • Humans
  • Public-Private Sector Partnerships*
  • Universities / organization & administration*